Short Report

You have full text access to this OnlineOpen article

Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: Burden and potential for prevention

  1. Xavier Castellsagué1,†,*,
  2. JoEllen Klaustermeier1,
  3. Carla Carrilho2,3,
  4. Ginesa Albero1,
  5. Jahit Sacarlal3,4,
  6. Wim Quint5,
  7. Bernhard Kleter5,
  8. Belen Lloveras1,
  9. Mamudo Rafik Ismail2,3,
  10. Silvia de Sanjosé1,
  11. F. Xavier Bosch1,
  12. Pedro Alonso4,6,
  13. Clara Menéndez4,6

Article first published online: 12 DEC 2007

DOI: 10.1002/ijc.23292

Issue

International Journal of Cancer

International Journal of Cancer

Volume 122, Issue 8, pages 1901–1904, 15 April 2008

Additional Information

How to Cite

Castellsagué, X., Klaustermeier, J., Carrilho, C., Albero, G., Sacarlal, J., Quint, W., Kleter, B., Lloveras, B., Ismail, M. R., de Sanjosé, S., Bosch, F. X., Alonso, P. and Menéndez, C. (2008), Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: Burden and potential for prevention. Int. J. Cancer, 122: 1901–1904. doi: 10.1002/ijc.23292

Author Information

  1. 1

    IDIBELL, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain

  2. 2

    Department of Pathology, Maputo Central Hospital, Maputo, Mozambique

  3. 3

    Department of Pathology, Faculty of Medicine, University Eduardo Mondlane, Maputo, Mozambique

  4. 4

    The Manhiça Health Research Center (CISM), Manhiça, Mozambique

  5. 5

    DDL Diagnostic Laboratory, Voorburg, The Netherlands

  6. 6

    Barcelona Center for International Health Research (CRESIB), Institut d'Investigacions Biomèdiques August Pi i Sunyer(IDIBAPS), Universtitat de Barcelona, Barcelona, Spain

  1. †

    Fax: (+34) 932607787

*Servei d'Epidemiologia i Registre del Càncer, Institut Català d'Oncologia, Gran via s/n, km 2.7, 08907 L'Hospitalet de Llobregat, Spain

Publication History

  1. Issue published online: 19 FEB 2008
  2. Article first published online: 12 DEC 2007
  3. Manuscript Accepted: 28 SEP 2007
  4. Manuscript Received: 19 JUN 2007

Funded by

  • Institut Català d'Oncologia (Barcelona)
  • Hospital Clinic (Barcelona)
  • Spanish Fondo de Investigación Sanitaria. Grant Numbers: FIS01/1236, FIS03/0240
  • DDL Diagnostic Laboratory (The Netherlands)
  • Spanish Agency for International Cooperation (AECI; CISM (Mozambique))

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (74K)

References

  • 1
    Parkin DM,Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006; 24 ( Suppl 3): S11–S25.
  • 2
    Harper DM,Franco EL,Wheeler CM,Moscicki AB,Romanowski B,Roteli-Martins CM,Jenkins D,Schuind A,Costa Clemens SA,Dubin G. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006; 367: 1247–55.
  • 3
    Kleter B,van Doorn LJ,Schrauwen L,Molijn A,Sastrowijoto S,ter Schegget J,Lindeman J,ter Harmsel B,Burger M,Quint W. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508–17.
  • 4
    Castellsague X,Menendez C,Loscertales MP,Kornegay JR,dos SF,Gomez-Olive FX,Lloveras B,Abarca N,Vaz N,Barreto A,Bosch FX,Alonso P. Human papillomavirus genotypes in rural Mozambique. Lancet 2001; 358: 1429–30.
  • 5
    Kleter B,van Doorn LJ,ter Schegget J,Schrauwen L,van Krimpen K,Burger M,ter Harmsel B,Quint W. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998; 153: 1731–9.
  • 6
    Munoz N,Bosch FX,de Sanjose S,Herrero R,Castellsague X,Shah KV,Snijders PJ,Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518–27.
  • 7
    Clifford G,Franceschi S,Diaz M,Munoz N,Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006; 24 ( Suppl 3): S26–S34.
  • 8
    Clifford GM,Gallus S,Herrero R,Munoz N,Snijders PJ,Vaccarella S,Anh PT,Ferreccio C,Hieu NT,Matos E,Molano M,Rajkumar R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991–8.
  • 9
    Menendez C,Castellsague X,Sacarlal J,Quintó Ll,Lloveras B,Klaustermeier J,Kornegay JR,Sigauque B,Bosch FX,Alonso PL. Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women from a rural area of Southern Mozambique. Clin Infect Dis, submitted.
  • 10
    Levi JE,Kleter B,Quint WG,Fink MC,Canto CL,Matsubara R,Linhares I,Segurado A,Vanderborght B,Neto JE,van Doorn LJ. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002; 40: 3341–5.
  • 11
    Naucler P,Da Costa FM,Ljungberg O,Bugalho A,Dillner J. Human papillomavirus genotypes in cervical cancers in Mozambique. J Gen Virol 2004; 85 (Part 8): 2189–90.
  • 12
    Carrilho C,Gouveia P,Cantel M,Alberto M,Buane L,David L. Characterization of human papillomavirus infection, P53 and Ki-67 expression in cervix cancer of Mozambican women. Pathol Res Pract 2003; 199: 303–11.
  • 13
    Carrilho C,Cirnes L,Alberto M,Buane L,Mendes N,David L. Distribution of HPV infection and tumour markers in cervical intraepithelial neoplasia from cone biopsies of Mozambican women. J Clin Pathol 2005; 58: 61–8.
  • 14
    Carrilho C. Cervical cancer in Mozambique: role of human papillomavirus (HPV) in the etiopathogenesis of cervix cancer and evaluation of the usefulness of some markers in the diagnosis, Doctoral Thesis, University of Oporto, Oporto, Portugal, 2005.
  • 15
    Bosch FX,Manos MM,Munoz N,Sherman M,Jansen AM,Peto J,Schiffman MH,Moreno V,Kurman R,Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796–802.
  • 16
    Khan MJ,Castle PE,Lorincz AT,Wacholder S,Sherman M,Scott DR,Rush BB,Glass AG,Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005; 97: 1072–9.
View Full Article (HTML) Get PDF (74K)